Oppenheimer Increases Church & Dwight (NYSE:CHD) Price Target to $120.00

Church & Dwight (NYSE:CHD) had its price objective lifted by investment analysts at Oppenheimer from $110.00 to $120.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target would indicate a potential upside of 13.26% from the company’s previous close.

Other equities analysts have also recently issued research reports about the company. The Goldman Sachs Group began coverage on Church & Dwight in a research report on Friday, March 1st. They set a “buy” rating and a $110.00 target price on the stock. TheStreet upgraded shares of Church & Dwight from a “c+” rating to a “b” rating in a research report on Friday, February 2nd. Truist Financial raised their price target on Church & Dwight from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. Royal Bank of Canada upped their price objective on shares of Church & Dwight from $94.00 to $103.00 and gave the company a “sector perform” rating in a research note on Monday, February 5th. Finally, Bank of America increased their price objective on shares of Church & Dwight from $100.00 to $104.00 and gave the stock a “neutral” rating in a report on Monday, April 15th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Church & Dwight presently has a consensus rating of “Hold” and a consensus price target of $104.07.

Church & Dwight Stock Up 1.5 %

Church & Dwight stock opened at $105.95 on Tuesday. The stock has a market capitalization of $25.84 billion, a price-to-earnings ratio of 34.85, a PEG ratio of 3.46 and a beta of 0.53. The company has a current ratio of 1.08, a quick ratio of 0.64 and a debt-to-equity ratio of 0.57. The stock has a 50 day moving average of $102.16 and a two-hundred day moving average of $96.68. Church & Dwight has a twelve month low of $82.25 and a twelve month high of $106.62.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings results on Friday, February 2nd. The company reported $0.65 earnings per share for the quarter, hitting the consensus estimate of $0.65. Church & Dwight had a return on equity of 20.28% and a net margin of 12.88%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.51 billion. During the same period last year, the company earned $0.62 earnings per share. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. As a group, research analysts expect that Church & Dwight will post 3.44 earnings per share for the current year.

Insider Activity

In related news, EVP Michael Read sold 4,500 shares of the firm’s stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $105.00, for a total value of $472,500.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Church & Dwight news, EVP Rene Hemsey sold 9,280 shares of the business’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $100.22, for a total transaction of $930,041.60. Following the completion of the transaction, the executive vice president now directly owns 6,373 shares of the company’s stock, valued at approximately $638,702.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael Read sold 4,500 shares of the firm’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $105.00, for a total transaction of $472,500.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 373,052 shares of company stock valued at $38,603,796. 1.40% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Church & Dwight

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Game Plan Financial Advisors LLC bought a new stake in Church & Dwight during the 1st quarter valued at $26,000. Roble Belko & Company Inc bought a new stake in shares of Church & Dwight during the first quarter valued at about $31,000. Chilton Capital Management LLC lifted its holdings in Church & Dwight by 50.0% in the fourth quarter. Chilton Capital Management LLC now owns 330 shares of the company’s stock worth $31,000 after purchasing an additional 110 shares during the period. Creekmur Asset Management LLC bought a new position in Church & Dwight in the 4th quarter valued at about $32,000. Finally, Annapolis Financial Services LLC increased its stake in Church & Dwight by 2,087.5% during the 4th quarter. Annapolis Financial Services LLC now owns 350 shares of the company’s stock valued at $33,000 after buying an additional 334 shares during the period. 86.60% of the stock is currently owned by institutional investors and hedge funds.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.